Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (59)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Reizis, B.
Right arrow Articles by Cohen, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reizis, B.
Right arrow Articles by Cohen, I. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 9, 43-51, Copyright © 1997 by Oxford University Press


ARTICLES

Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7

B Reizis, M Eisenstein, J Bockova, S Konen-Waisman, F Mor, D Elias and IR Cohen
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

The MHC class II molecule of the non-obese diabetic (NOD) mice, I-Ag7, is associated with susceptibility to autoimmune diabetes. To try to understand the molecular basis of this association, we analyzed the peptide binding properties and intracellular behavior of I-Ag7 in comparison with other I-A haplotypes. We found that I-Ag7 molecules manifested normal intracellular trafficking and lifespan, and a small but clearly detectable fraction of I-Ag7 in the cells formed SDS- resistant compact dimers. The binding of an antigenic reference peptide to I-Ag7 was stable and was accompanied by compact dimer formation. Our analysis of the binding specificity of I-Ag7 revealed a peptide binding motif of nine amino acids with a degenerate position at P1 and three conserved anchor positions: P4, P6 and P9. An allele-specific preference for negatively charged residues was found at P9, apparently due to the presence of the rare Ser residue at position 57 of the I-Ag7 beta chain. These findings could have implications for the mechanisms of MHC-mediated susceptibility to autoimmune diabetes in the NOD mice.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Mukherjee, D. Wagar, T. A. Stephens, E. Lee-Chan, and B. Singh
Identification of CD4+ T Cell-Specific Epitopes of Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein: A Novel {beta} Cell Autoantigen in Type 1 Diabetes
J. Immunol., May 1, 2005; 174(9): 5306 - 5315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. H. Koonce and E. K. Bikoff
Dissecting MHC Class II Export, B Cell Maturation, and DM Stability Defects in Invariant Chain Mutant Mice
J. Immunol., September 1, 2004; 173(5): 3271 - 3280.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. C. Anderson and V. K. Kuchroo
Expression of Self-antigen in the Thymus: A Little Goes a Long Way
J. Exp. Med., December 1, 2003; 198(11): 1627 - 1629.
[Full Text] [PDF]


Home page
Mol. Pathol.Home page
M A Kelly, M L Rayner, C H Mijovic, and A H Barnett
Molecular aspects of type 1 diabetes
Mol. Pathol., February 1, 2003; 56(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Suri, I. Vidavsky, K. van der Drift, O. Kanagawa, M. L. Gross, and E. R. Unanue
In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket
J. Immunol., February 1, 2002; 168(3): 1235 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Koarada, Y. Wu, and W. M. Ridgway
Increased Entry into the IFN-{gamma} Effector Pathway by CD4+ T Cells Selected by I-Ag7 on a Nonobese Diabetic Versus C57BL/6 Genetic Background
J. Immunol., August 1, 2001; 167(3): 1693 - 1702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Judkowski, C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson
Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice
J. Immunol., January 15, 2001; 166(2): 908 - 917.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Stratmann, V. Apostolopoulos, V. Mallet-Designe, A. L. Corper, C. A. Scott, I. A. Wilson, A. S. Kang, and L. Teyton
The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder
J. Immunol., September 15, 2000; 165(6): 3214 - 3225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. S. Arneson, M. Peterson, and A. J. Sant
The MHC Class II Molecule I-Ag7 Exists in Alternate Conformations That Are Peptide Dependent
J. Immunol., August 15, 2000; 165(4): 2059 - 2067.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Gregori, E. Bono, F. Gallazzi, J. Hammer, L. C. Harrison, and L. Adorini
The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library
Int. Immunol., April 1, 2000; 12(4): 493 - 503.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Carrasco-Marin, O. Kanagawa, and E. R. Unanue
The lack of consensus for I-Ag7-peptide binding motifs: Is there a requirement for anchor amino acid side chains?
PNAS, July 20, 1999; 96(15): 8621 - 8626.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. H.F. Hausmann, B. Yu, S. Hausmann, and K. W. Wucherpfennig
pH-dependent Peptide Binding Properties of the Type I Diabetes-associated I-Ag7 Molecule: Rapid Release of CLIP at an Endosomal pH
J. Exp. Med., June 7, 1999; 189(11): 1723 - 1734.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Elias, Y. Tikochinski, G. Frankel, and I. R. Cohen
Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide
Int. Immunol., June 1, 1999; 11(6): 957 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gregori, S. Trembleau, G. Penna, F. Gallazzi, J. Hammer, G. K. Papadopoulos, and L. Adorini
A Peptide Binding Motif for I-Eg7, the MHC Class II Molecule That Protects E{alpha}-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes
J. Immunol., June 1, 1999; 162(11): 6630 - 6640.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok
Exceptional Stability of the HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Molecule Associated with Protection from Insulin-Dependent Diabetes Mellitus
J. Immunol., December 1, 1998; 161(11): 6439 - 6445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Peterson and A. J. Sant
The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM
J. Immunol., September 15, 1998; 161(6): 2961 - 2967.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Kanagawa, S. M. Martin, B. A. Vaupel, E. Carrasco-Marin, and E. R. Unanue
Autoreactivity of T cells from nonobese diabetic mice: An I-Ag7-dependent reaction
PNAS, February 17, 1998; 95(4): 1721 - 1724.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.